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Abstract. In the context of SARS-CoV-2 pandemic, the hospital management of mother-infant pairs poses to obstetricians
and neonatologists previously unmet challenges. In Lombardy, Northern Italy, 59 maternity wards networked to organise the
medical assistance of mothers and neonates with suspected or confirmed SARS-CoV-2 infection. Six “COVID-19 maternity
centres” were identified, the architecture and activity of obstetric and neonatal wards of each centre was reorganised, and
common assistance protocols for the management of suspected and proven cases were formulated. Here, we present the
key features of this reorganization effort, and our current management of the mother-infant dyad before and after birth,
including our approach to rooming-in practice, breastfeeding and neonatal follow-up, based on the currently available scientific
evidence. Considered the rapid diffusion of COVID-19 all over the world, we believe that preparedness is fundamental to
assist mother-infant dyads, minimising the risk of propagation of the infection through maternity and neonatal wards.
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1. Introduction
In December 2019, the novel Betacoronavirus
SARS-CoV-2 was identified in a cluster of few
Chinese adults suffering from severe pneumonia.
The disease was named “COVID-19” [1]. Since
late February 2020, Italy has been dramatically
∗Address for correspondence: Carlo Pietrasanta, Via della
Commenda 12, 20122 Milan, Italy. Tel.: +39 333 7505802;
Fax: +39 02 5503 2217; E-mails: carlo.pietrasanta@gmail.com;
carlo.pietrasanta@unimi.it.
overwhelmed by the epidemic, with 201.505 cases
reported until April 28, 2020, and 27.359 deaths.
Forty-three percent of these patients were clustered
in Lombardy, Northern Italy [2].
The possibility of vertical transmission of SARS-
CoV-2 from a mother to the fetus is largely unknown,
but seems possible based on limited data [3]. Post-
partum transmission of SARS-CoV-2 from parents to
neonates seems far more common, likewise several
viral agents that cause respiratory infections [3, 4].
Thus, in such a pandemic context, the management
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of the mother-infant dyad before and after birth poses
to obstetricians and neonatologists previously unmet
challenges.
On February 26, six days after the beginning of
SARS-CoV-2 epidemic in Lombardy, the regional
committee of Societa´ Italiana di Neonatologia (SIN)
in coordination with regional branches of the Italian
Society of Obstetrics and Gynecology (SIGO) and
local authorities started to plan the assistance of pos-
itive or suspected mother-infant dyads. Here, based
on available recommendations [5–8], published data,
and on-field experience, we present an overview of
how this assistance was organized, and how we are
currently managing mothers and infants with sus-
pected or proven SARS-Cov-2 infection before and
after birth.
2. Identification and reorganization of
COVID-19 maternity centers
Lombardy hosts 59 maternity hospitals, for a
population of approximately 10 million people and
75.000 births/year. A system of in-utero and neonatal
emergency transportation, organized around 11 hub
centers with a level III neonatal intensive care unit
(NICU) and Maternal-Fetal Medicine (MFM) cen-
ter, has been connecting maternity hospitals since
1992. On February 26, five of these hubs were
designated to centralize all cases of suspected or con-
firmed SARS-CoV-2 infection in pregnant mothers
and neonates, up to 28 days of life. The choice was
based on the location and the availability of spaces
suitable to isolate mothers and infants, as well as on
the presence of infectious disease consultant on-site
24/7 and an adult intensive care unit with dedicated
COVID-19 areas and staff. Within each “COVID-
19 maternity center”, dedicated spaces and routes to
assist mothers and infants with suspected or proven
SARS-CoV-2 infection were identified. In obstetric
triage, pediatric triage, and delivery wards one or
more (depending on availability) rooms with neg-
ative pressure and en-suite toilet were dedicated to
assist women and neonates with suspected or proven
infection. In NICUs, negative-pressure rooms were
identified at one extremity of the ward, to cohort con-
firmed (the farthest from the ward) and suspected
(the closest) neonates requiring medical assistance,
respectively. If possible, similar rooms were identi-
fied and equipped in the nursery, to assist non-critical
neonates whose mothers were not in sufficient condi-
tion for rooming-in (see below). One-way routes for
healthcare-providers and materials were identified,
and both entrance were equipped with double doors
and stations for donning and doffing of PPE. When
necessary, and elevator was removed from public
availability, locked and dedicated to the COVID-19
course.
3. Medical management
The high contagiousness of SARS-CoV-2 and the
actual pandemic situation impose extreme caution in
the management of suspected or proven infections,
regardless of the patient’s age. Every staff member
who enters a room hosting a patient with suspected
or proven SARS-CoV-2 infection, either a woman
or a neonate, always dons full personal protective
equipment (PPE: N95 or superior respirator, double
gloves, splash-proof gown and head cuff, goggles or
face shield, and shoe covers).
3.1. Pre-partum assistance to the pregnant
mother
Based on regulations given by the Italian Min-
istry of Health, universal testing of pregnant women
for SARS-CoV-2 is not performed. All pregnant
women are interviewed at hospital admission for
symptoms or anamnestic data suggestive for SARS-
CoV-2 infection. The interview also covers partner,
cohabitants and relatives. In case of clinical sus-
picion, to confirm or exclude infection (rt-PCR on
nasopharyngeal swab) [5] before the woman accesses
delivery room is of paramount importance. Pending
the screening result, the woman remains isolated in
obstetric triage. Whenever the staff is in the room,
patients not requiring respiratory support must don
a surgical mask. If infection is unconfirmed, the
woman is cared through normal assistance protocol.
In case of delivery from a confirmed or still suspected
mother, the woman is transferred to the maternity
ward through the COVID-19 route, by obstetric staff
donning full PPE, and is assisted during delivery
by a dedicated multidisciplinary team (obstetrician,
gynecologist, anesthesiologist, neonatologist, neona-
tal nurse) in isolation room.
3.2. Post-partum assistance to the mother-infant
dyad
After birth, skin-to-skin procedure is avoided
on a precautionary basis. The management of
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mother-infant dyad depends on the clinical condition
of both, and on the results of SARS-CoV-2 infection
screening.
Possible postpartum scenarios are summarized in
Table 1. All scenarios (A, B, C) share common man-
agement features.
3.2.1. Staff equipment and assistance
organization
In case of positive or suspected maternal or neona-
tal infection, both obstetric and neonatal staff dons
full PPE, as highlighted above. Based on epidemi-
ological data, the need for highly intensive care is
uncommon for neonates born to mothers with SARS-
CoV-2 infection [3]. Nonetheless, preterm neonates
may require full medical assistance, independently
from the infection. Thus, nursing and medical shifts
in the NICU isolation rooms are adjusted daily, based
on the clinical severity of admitted neonates. In post-
partum ward, one midwife every 4–6 women per shift
is dedicated exclusively to the assistance of isolated
mothers.
3.2.2. Transfer of mother and infant between
hospital wards
Obstetric staff, plus an anesthesiologist and ICU
specialists if needed, transfers the mother through
dedicated route to the isolation room in post-partum
area or ICU, donning full PPE. The mother dons a
surgical mask if she doesn’t need respiratory sup-
port. In scenario “A”, the neonate can be transferred
together with the mother by obstetric staff, after
neonatologist’s approval. In scenario “B” and “C” the
neonate is transferred into dedicated transport incuba-
tor by fully equipped NICU staff to the isolation room
in the appropriate neonatal ward area (nursery or
NICU).
3.2.3. Rooming-in
Based on actual, limited evidence, rooming-in of
the neonate in case of scenario “A” is not contraindi-
cated [8]. Within the room, the mother is instructed to
don a surgical mask and perform careful hand hygiene
before assisting the neonate. When mask is not worn,
mother and neonate must remain at a minimum dis-
tance of 6 feet apart, and a curtain should be placed
between mother and baby.
3.2.4. Testing of the neonate for SARS-CoV-2
If the mother tested positive, the neonate is
screened for SARS-CoV-2 infection within the first
12 hours of life (nasopharyngeal swab, urine, blood,
Ta
bl
e
1
M
an
ag
em
en
to
fm
o
th
er
-
in
fa
n
td
ya
ds
ba
se
d
o
n
cl
in
ic
al
co
n
di
tio
ns
an
d
v
iro
lo
gi
ca
ls
cr
ee
n
in
g
fo
rS
A
RS
-C
oV
-
2
in
fe
ct
io
n
Cl
in
ic
al
sc
en
ar
io
M
at
er
na
lS
A
RS
-
Co
V-
2
sc
re
en
in
g
N
eo
na
ta
lS
A
RS
-
Co
V-
2
sc
re
en
in
g
Cl
in
ic
al
co
n
di
tio
ns
∗
A
re
a
o
f
H
os
pi
ta
liz
at
io
n
Is
ol
at
io
n
ro
o
m
R
oo
m
in
g-
in
B
re
as
tfe
ed
in
g
A
Po
sit
iv
e
o
r
pe
nd
in
g
Pe
nd
in
g
M
ot
he
r:
go
od
N
eo
na
te
:g
oo
d
M
ot
he
ra
n
d
in
fa
n
t:
po
st-
pa
rtu
m
w
ar
d
Ye
s
Ye
s
A
llo
w
ed
B
Po
sit
iv
e
o
r
pe
nd
in
g
Pe
nd
in
g
M
ot
he
r:
go
od
M
ot
he
r:
po
st-
pa
rtu
m
w
ar
d
Ye
s
(co
ho
rti
ng
al
lo
w
ed
)
N
o
D
ire
ct
br
ea
stf
ee
di
ng
n
o
tf
ea
sib
le
N
eo
na
te
:r
eq
ui
rin
g
as
sis
ta
nc
e
In
fa
n
t:
N
IC
U
Ex
pr
es
se
d
m
ilk
ad
m
in
ist
er
ed
by
N
IC
U
st
af
fa
llo
w
ed
C
Po
sit
iv
e
o
r
pe
nd
in
g
Pe
nd
in
g
M
ot
he
r:
re
qu
iri
ng
as
sis
ta
nc
e
N
eo
na
te
:g
oo
d
M
ot
he
r:
po
st-
pa
rtu
m
w
ar
d
o
r
IC
U
In
fa
n
t:
N
ur
se
ry
Ye
s
(co
ho
rti
ng
al
lo
w
ed
)
N
o
D
ire
ct
br
ea
stf
ee
di
ng
n
o
tf
ea
sib
le
Ex
pr
es
se
d
m
ilk
ad
m
in
ist
er
ed
by
N
IC
U
st
af
fa
llo
w
ed
∗ G
oo
d
cl
in
ic
al
co
n
di
tio
ns
,m
o
th
er
s:
n
o
t
re
qu
iri
ng
re
sp
ira
to
ry
su
pp
or
t,
fe
v
er
<
38
◦ C
,a
bl
e
to
ta
ke
ca
re
o
fh
er
ba
by
ac
co
rd
in
g
to
th
e
tr
ea
tin
g
ph
ys
ic
ia
n.
G
oo
d
Cl
in
ic
al
co
n
di
tio
ns
,n
eo
n
at
es
:
n
o
t
re
qu
iri
ng
re
sp
ira
to
ry
su
pp
or
t,
n
o
rm
al
v
ita
ls,
n
o
sig
ns
o
r
sy
m
pt
om
so
fs
u
sp
ec
te
d
se
ps
is
ac
co
rd
in
g
to
CD
C
cr
ite
ria
,a
bl
e
to
fe
ed
re
gu
la
rly
.
Co
rec
ted
 P
roo
f
4 C. Pietrasanta et al. / SARS-CoV-2 infection in the perinatal period
rectal swab). In scenario “A”, the neonate is not
separated from the mother even in case of discor-
dant results (mother positive, neonate negative at
birth screening). In scenario “B” and “C”, positive
neonates are cohorted in dedicated COVID-19 areas
within the NICU or nursery. Negative neonates at
birth screening remain cohorted with suspected cases,
given the actual paucity of data regarding the possi-
bility of SARS-CoV-2 vertical transmission and viral
shedding.
3.2.5. Breastfeeding
Based on limited evidence [3, 8], and after care-
ful discussion with parents, the use of mother’s milk
is not discouraged for any scenario. In scenario “A”,
direct breastfeeding is not discouraged. In “B” and
“C” scenarios, mother can express milk, administered
to the neonate by the NICU/nursery staff. Careful
hand hygiene with 70% alcohol solution is recom-
mended before using the milk pump.
3.2.6. Parental visits
Considered the pandemic situation and the fact that
partners are close contacts of mothers, visits of any
relative, including father, to the dyad are not permit-
ted.
3.3. Assistance to neonates admitted from home,
or from other hospitals, with
confirmed/suspected infection
Neonates accessing the pediatric triage with sus-
pected infection are isolated with parents in the
dedicated COVID-19 area. Screening for SARS-
CoV-2 infection (nasopharyngeal swab) is performed
in the pediatric triage. In case of positive test, the
neonate is admitted to the appropriate COVID-19
area of the neonatal ward. Both parents are tested
as well, and quarantined at home if not in need
for immediate medical assistance. Parental visit to
the admitted baby are not permitted. Expressing
breast milk to feed the admitted baby is not con-
traindicated. Nonetheless, considered the mandatory
strict parental quarantine, formula feed is admin-
istered to the neonate until parental quarantine
is over.
3.4. Hospital discharge and follow-up
The rapidly changing pandemic situation of
COVID-19, the limited evidence-based data and
different local policies hinder definitive and uni-
versal recommendations on the management of
maternal-infant dyads after hospital discharge. Clin-
ical conditions of mother and neonate seem the best
indicator for hospital discharge of the dyad. Labo-
ratory resolution of the infection (i.e. two negative
nasopharyngeal swabs 24 hours apart) [5] is not con-
sidered a mandatory criterion to discharge the dyad
home. In case of positive mother or infant, provided
good clinical conditions of both, the whole family is
quarantined home. Mother and neonate are re-tested
for SARS-CoV-2 14 days after hospital discharge, in
dedicated areas of obstetric triage equipped to visit
the infant as well. For transportation from home to
hospital and back, the use of personal vehicle, if
available, is recommended. Parents must always don
surgical masks outside home. Recommendations on
how to continue clinical and virological follow-up
on mother-infant dyads are not available at present.
Anyway, in case of persistent positivity, virological
screening is carried on until confirmed negativ-
ity (two negative nasopharyngeal swabs 24 hours
apart).
4. Conclusions
After spreading out of Chinese borders, COVID-
19 is rapidly diffusing all over the world, and several
healthcare systems are predicted to be overwhelmed
by the pandemic within the next weeks. The aim
of this work is to share our experience, as obste-
tricians and neonatologists, on the management of
mother-infant dyads with suspected or confirmed
SARS-CoV-2 infection, in a highly epidemic Euro-
pean region that is currently facing a sanitary
emergency. Our purpose is also to encourage debate
on several, still poorly known aspects of COVID-
19 management in pregnant mothers and neonates.
Considered the projected numbers of this sanitary
crisis worldwide, maternity wards and NICUs should
rapidly prepare for the management of suspected or
proven SARS-CoV-2 infections.
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